!

COVID-19 Response 

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Department of Molecular Virology and Microbiology

Commercial Development

Master
Heading

Companies, Licensing and Patents

Content

See information on the companies, licensing and patents that are associated with the commercial development area of the Department of Molecular Virology and Microbiology. 

Heading

Companies

Content

Diversigen Inc.

Formed by Joe Petrosino, Ph.D., with the Alkek Center for Metagenomics & Microbiome Research (CMMR) to engage the CMMR to perform services on behalf of third-party biotech and pharmaceutical company clients. World-class Business on Demand facilitating pharma relationships. Exclusive license agreement signed 2015.

View website: Diversigen Inc.

Twister Biotechnology Inc.

Formed by Lynn Zechiedrich, Ph.D., to provide services and reagents involving the custom production of DNA minivectors to meet customer specifications. Exclusive license agreement signed 2011.

View website: Twister Biotechnology, Inc.

Speratum CR, SA

Formed by Christian Marin-Mueller, Ph.D., a former graduate student in lab of Qizhi “Cathy” Yao, M.D., Ph.D., to develop an miRNA 198-based therapeutic approach to the treatment of pancreatic cancer and other malignancies. Exclusive license agreement signed 2015.

View website: Speratum CR, SA 

Heading

Licensing

Content

ImmuCell

Years of basic research on rotavirus and vaccine candidate virus-like particles by Dr. Mary EstesDr. Sue CrawfordDr. Margaret E. ConnerDr. Sarah E. Blutt and others leads to a licensing agreement with ImmuCell and the development of a product to protect newborn calves from the diarrhea-causing disease.

View website: Immucell 

Takeda Pharmaceuticals

Developing a Human Norovirus Vaccine Candidate TAK-214

View website: Takeda Pharmaceuticals

Heading

Patents

Content

Patents applied for and awarded to our faculty.

View Patent Listing